Quarterly report pursuant to Section 13 or 15(d)

Related-Party Transactions

v3.3.0.814
Related-Party Transactions
9 Months Ended
Sep. 30, 2015
Related Party Transactions [Abstract]  
Related-Party Transactions

10. Related-Party Transactions

The Company paid a former member of its Board of Directors, who is also a key scientific and clinical advisor to the Company, a total of $60,000 in the year ended December 31, 2014 and $45,000 for the nine months ended September 30, 2015, in monthly cash retainers. The Company also issued options to purchase shares of common stock and incentive awards to this individual in his capacity as a key scientific and clinical advisor.